APOPTOSIS-INDUCING AGENT FOR PROSTATE CANCER CELLS
    2.
    发明申请
    APOPTOSIS-INDUCING AGENT FOR PROSTATE CANCER CELLS 有权
    用于前列腺癌细胞的病毒诱导剂

    公开(公告)号:US20110166545A1

    公开(公告)日:2011-07-07

    申请号:US13006198

    申请日:2011-01-13

    CPC分类号: C07K14/4747 A61K38/00

    摘要: According to the present invention, an apoptosis-inducing agent for prostate cancer comprising REIC/Dkk-3 DNA or an REIC/Dkk-3 protein, and a therapeutic agent for prostate cancer and an agent for inhibiting prostate cancer metastasis that comprise such apoptosis-inducing agent are provided.An apoptosis-inducing agent for prostate cancer, comprising, as an active ingredient, an REIC/Dkk-3 protein (a) or (b) or REIC/Dkk-3 DNA (c) or (d): (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2; (b) a protein consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by substitution or deletion of 1 or more amino acids; (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1; or (d) DNA that hybridizes under stringent conditions to DNA consisting of a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO: 1 and encodes a protein having apoptosis activity; and a therapeutic agent for prostate cancer comprising such apoptosis-inducing agent are provided

    摘要翻译: 根据本发明,包含REIC / Dkk-3 DNA或REIC / Dkk-3蛋白的前列腺癌细胞凋亡诱导剂,前列腺癌治疗剂和抑制前列腺癌转移的药剂, 提供诱导剂。 一种用于前列腺癌的凋亡诱导剂,其包含REIC / Dkk-3蛋白(a)或(b)或REIC / Dkk-3 DNA(c)或(d)作为活性成分:(a)蛋白质 由SEQ ID NO:2表示的氨基酸序列组成; (b)通过取代或缺失1个或多个氨基酸由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的蛋白质; (c)由SEQ ID NO:1表示的核苷酸序列组成的DNA; 或(d)在严格条件下与由与SEQ ID NO:1所示的核苷酸序列互补的核苷酸序列组成的DNA杂交的DNA,并编码具有凋亡活性的蛋白质; 并提供包含这种凋亡诱导剂的前列腺癌治疗剂

    Partial Fragment of REIC/Dkk-3 Gene and Cancer Therapeutic Agent Comprising the Same
    3.
    发明申请
    Partial Fragment of REIC/Dkk-3 Gene and Cancer Therapeutic Agent Comprising the Same 有权
    REIC / Dkk-3基因的部分片段和包含其的癌症治疗剂

    公开(公告)号:US20130274199A1

    公开(公告)日:2013-10-17

    申请号:US13925041

    申请日:2013-06-24

    IPC分类号: C07K16/18

    摘要: This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.

    摘要翻译: 本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。

    Therapeutic Agent for Malignant Mesothelioma and Immunostimulant
    4.
    发明申请
    Therapeutic Agent for Malignant Mesothelioma and Immunostimulant 有权
    恶性间皮瘤和免疫刺激剂的治疗剂

    公开(公告)号:US20110189237A1

    公开(公告)日:2011-08-04

    申请号:US13056443

    申请日:2009-07-30

    摘要: According to the present invention, a method for treating malignant mesothelioma using REIC/Dkk-3 and a therapeutic agent for malignant mesothelioma comprising REIC/Dkk-3 are provided. A mesothelioma therapeutic agent is provided, comprising the following REIC/Dkk-3 DNA or a vector comprising the DNA as an active ingredient: (a) a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1; or (b) a DNA hybridizing under stringent conditions to a DNA consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 and encoding a protein having apoptosis-inducing activity and IL-7 production-accelerating activity in cells.

    摘要翻译: 根据本发明,提供了使用REIC / Dkk-3治疗恶性间皮瘤的方法和包含REIC / Dkk-3的恶性间皮瘤治疗剂。 提供间皮瘤治疗剂,其包含以下REIC / Dkk-3 DNA或包含该DNA作为活性成分的载体:(a)由SEQ ID NO:1所示核苷酸序列组成的DNA; 或(b)在严格条件下与由与SEQ ID NO:1所示核苷酸序列互补的核苷酸序列组成的DNA杂交并编码细胞中具有凋亡诱导活性和IL-7生产加速活性的蛋白质的DNA。

    Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
    5.
    发明申请
    Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same 有权
    REIC / Dkk-3基因的部分片段和包含其的癌症治疗剂

    公开(公告)号:US20100173404A1

    公开(公告)日:2010-07-08

    申请号:US12447044

    申请日:2007-10-24

    摘要: This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.

    摘要翻译: 本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。

    Apoptosis-Inducing Agent for Prostate Cancer Cells
    6.
    发明申请
    Apoptosis-Inducing Agent for Prostate Cancer Cells 审中-公开
    前列腺癌细胞凋亡诱导剂

    公开(公告)号:US20090005538A1

    公开(公告)日:2009-01-01

    申请号:US11886338

    申请日:2006-01-10

    IPC分类号: C07K14/00

    CPC分类号: C07K14/4747 A61K38/00

    摘要: According to the present invention, an apoptosis-inducing agent for prostate cancer comprising REIC/Dkk-3 DNA or an REIC/Dkk-3 protein, and a therapeutic agent for prostate cancer and an agent for inhibiting prostate cancer metastasis that comprise such apoptosis-inducing agent are provided.An apoptosis-inducing agent for prostate cancer, comprising, as an active ingredient, an REIC/Dkk-3 protein (a) or (b) or REIC/Dkk-3 DNA (c) or (d): (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2; (b) a protein consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 by substitution or deletion of 1 or more amino acids; (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1; or (d) DNA that hybridizes under stringent conditions to DNA consisting of a nucleotide sequence complementary to the nucleotide sequence represented by SEQ ID NO: 1 and encodes a protein having apoptosis activity; and a therapeutic agent for prostate cancer comprising such apoptosis-inducing agent are provided

    摘要翻译: 根据本发明,包含REIC / Dkk-3 DNA或REIC / Dkk-3蛋白的前列腺癌细胞凋亡诱导剂,前列腺癌治疗剂和抑制前列腺癌转移的药剂, 提供诱导剂。 一种用于前列腺癌的凋亡诱导剂,其包含REIC / Dkk-3蛋白(a)或(b)或REIC / Dkk-3 DNA(c)或(d)作为活性成分:(a)蛋白质 由SEQ ID NO:2表示的氨基酸序列组成; (b)通过取代或缺失1个或多个氨基酸由SEQ ID NO:2所示的氨基酸序列衍生的氨基酸序列组成的蛋白质; (c)由SEQ ID NO:1表示的核苷酸序列组成的DNA; 或(d)在严格条件下与由与SEQ ID NO:1所示的核苷酸序列互补的核苷酸序列组成的DNA杂交的DNA,并编码具有凋亡活性的蛋白质; 并提供包含这种凋亡诱导剂的前列腺癌治疗剂

    Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
    7.
    发明授权
    Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same 有权
    REIC / Dkk-3基因的部分片段和包含其的癌症治疗剂

    公开(公告)号:US08618273B2

    公开(公告)日:2013-12-31

    申请号:US12447044

    申请日:2007-10-24

    IPC分类号: C07H21/02 C07H21/04

    摘要: This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.

    摘要翻译: 本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。

    Direct administration of REIC/Dkk-3 to mesothelioma
    10.
    发明授权
    Direct administration of REIC/Dkk-3 to mesothelioma 有权
    将REIC / Dkk-3直接给予间皮瘤

    公开(公告)号:US09475865B2

    公开(公告)日:2016-10-25

    申请号:US13925041

    申请日:2013-06-24

    摘要: This invention provides an inducer of apoptosis in cancer cells comprising a fragment of the REIC/Dkk-3 gene and a cancer therapeutic agent comprising the same. This invention also provides a polynucleotide fragment encoding the REIC/Dkk-3 protein (a) or (b), which encodes a polypeptide having apoptosis activity: (a) a polynucleotide encoding a polypeptide comprising an amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2; or (b) a polynucleotide encoding a polypeptide comprising an amino acid sequence derived from the amino acid sequence of amino acid 1 to any of amino acids 39 to 78 of the amino acid sequence of the REIC/Dkk-3 protein as shown in SEQ ID NO: 2 by substitution, deletion, or addition of 1 or several amino acids and having apoptosis activity.

    摘要翻译: 本发明提供了包含REIC / Dkk-3基因的片段的癌细胞中的凋亡诱导剂和包含其的癌症治疗剂。 本发明还提供编码具有凋亡活性的多肽的编码REIC / Dkk-3蛋白(a)或(b)的多核苷酸片段:(a)编码包含氨基酸1的氨基酸序列的多肽的多核苷酸至任何 的如SEQ ID NO:2所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸39至78; 或(b)编码多肽的多核苷酸,其包含衍生自SEQ ID NO:1所示的REIC / Dkk-3蛋白的氨基酸序列的氨基酸1至氨基酸39至78的氨基酸序列的氨基酸序列的氨基酸序列 NO:2通过取代,缺失或添加1个或几个氨基酸并具有凋亡活性。